Arcutis Biotherapeutics I...

15.73
-0.36 (-2.24%)
At close: Mar 28, 2025, 3:59 PM
15.74
0.08%
After-hours: Mar 28, 2025, 06:36 PM EDT

Arcutis Biotherapeutics Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue 196.54M 59.61M 3.69M n/a n/a n/a n/a n/a
Cost of Revenue 19.13M 4.99M 754K 763K 455K 195K n/a n/a
Gross Profit 177.41M 54.62M 2.93M -763K -455K -195K n/a n/a
Operating Income -128.4M -241.1M -301.63M -206.53M -136.65M -43.13M -19.73M -4.11M
Interest Income n/a n/a 9.83M 173K 967K 1.14M n/a n/a
Pretax Income -139.39M -259.03M -311.46M -206.36M -135.68M -42M -19.25M -4.98M
Net Income -140.04M -262.14M -321.29M -205.9M -135.68M -42M -19.25M -4.98M
Selling & General & Admin 229.39M 185.15M 122.12M 60.97M 21.34M 6.61M 1.79M 695K
Research & Development 76.42M 110.58M 182.44M 145.56M 115.31M 36.52M 17.94M 3.41M
Other Expenses n/a n/a 5.82M 173K 967K 1.14M 480K -872K
Operating Expenses 305.81M 295.72M 304.56M 206.53M 136.65M 43.13M 19.73M 4.11M
Interest Expense 27.17M 29.71M 15.65M n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 324.94M 300.71M 305.31M 206.53M 136.65M 43.13M 19.73M 4.11M
Income Tax 647K 3.11M 9.83M -454K -84.3K 23.14K -480K -4.11M
Shares Outstanding (Basic) 120.96M 69.31M 55.03M 49.41M 35.67M 38.09M 36.24M 36.24M
Shares Outstanding (Diluted) 120.96M 69.31M 55.03M 49.41M 35.67M 38.09M 36.24M 36.24M
EPS (Basic) -1.16 -3.78 -5.84 -4.17 -3.8 -1.1 -0.53 -0.14
EPS (Diluted) -1.16 -3.78 -5.84 -4.17 -3.8 -1.1 -0.53 -0.14
EBITDA -109.63M -227.43M -294.55M -205.59M -135.22M -41.8M 480K -872K
Depreciation & Amortization 2.6M 1.88M 1.25M 763K 455K 195K 19.73M 4.11M